Literature DB >> 22447427

[Botulinum toxin for ocular complications after facial palsy].

E Torres Suárez1.   

Abstract

Sequelae of facial palsy are often underdiagnosed. The ophthalmologist plays a pivotal role in the acute, subacute and chronic treatment of this condition. Goals are to provide corneal protection, restoration of facial asymmetry and facial movements and the treatment of crocodile tears. Botulinum toxin is the first line treatment for sequelae due to aberrant regeneration. The indications and techniques for treatment with botulinum toxin in patients with facial palsy are presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447427     DOI: 10.1007/s00347-012-2536-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  12 in total

Review 1.  Review and update of involuntary facial movement disorders presenting in the ophthalmological setting.

Authors:  Adam H Ross; John S Elston; Marie-Helene Marion; Raman Malhotra
Journal:  Surv Ophthalmol       Date:  2010-11-20       Impact factor: 6.048

2.  Eyebrow asymmetry: definition and symmetrical correction using botulinum toxin A.

Authors:  Tunc Tiryaki; N Sinem Eroglu Ciloglu
Journal:  Aesthet Surg J       Date:  2007 Sep-Oct       Impact factor: 4.283

3.  Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation.

Authors:  David J Keegan; Gerd Geerling; John P Lee; Glen Blake; J Richard Collin; Gordon T Plant
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

4.  [Botulinum toxin treatment of synkinesia following facial paralysis].

Authors:  P Roggenkämper; R Laskawi; W Damenz; M Schröder; Z Nüssgens
Journal:  HNO       Date:  1990-08       Impact factor: 1.284

5.  Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.

Authors:  Gary Borodic; Mary Bartley; William Slattery; Michael Glasscock; Eric Johnson; Carl Malazio; Michael Goodnough; Martin Acquadro; Michael McKenna
Journal:  Plast Reconstr Surg       Date:  2005-07       Impact factor: 4.730

6.  [Psychosocial problems and coping with illness by patients with defective healing after facial paralysis].

Authors:  C Kiese-Himmel; R Laskawi; S Wrede
Journal:  HNO       Date:  1993-05       Impact factor: 1.284

7.  Aberrant facial nerve regeneration (AFR): an under-recognized cause of ptosis.

Authors:  C Chen; R Malhotra; J Muecke; G Davis; D Selva
Journal:  Eye (Lond)       Date:  2004-02       Impact factor: 3.775

Review 8.  Ophthalmic management of facial nerve palsy.

Authors:  V Lee; Z Currie; J R O Collin
Journal:  Eye (Lond)       Date:  2004-12       Impact factor: 3.775

9.  Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.

Authors:  M N Naik; N Gangopadhyay; M Fernandes; R Murthy; S G Honavar
Journal:  Eye (Lond)       Date:  2007-05-18       Impact factor: 3.775

10.  Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.

Authors:  B Boroojerdi; A Ferbert; M Schwarz; H Herath; J Noth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.